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n).© 2019 Elsevier Inc. All rights reserved.Oral ﬂuids (saliva, mouthrinse, gingival crevicular ﬂuid [GCF], and
peri-implant sulcular ﬂuid [PISF]) provide a matrix for periodontitis
and dental peri-implant biomarker diagnostics as recently studied by
Schmalz et al. (2019). In periodontitis and peri-implantitis, elevated
levels of neutrophil collagenase or collagenase-2, especially in active/
activated form, reﬂect, predict, and monitor the diagnosis, course,
and treatment of these diseases. Oral ﬂuid active matrix
metalloproteinase-8 (aMMP-8)/neutrophil collagenase is a potential
point-of-care (PoC)/chairside biomarker for these diseases, and com-
mercially available aMMP-8 PoC tests have been developed and are inuse. GCF and PISF have often been sampled at individual sites usingﬁlter
papers and/ormicropipettes (Rathnayake et al. 2017), but there is an al-
ternative way to sample GCF: a wash using a mouthrinse technique
(Drouin et al. 1988; Gangbar et al. 1990). This simpler technique utiliz-
ing mouthrinse has been developed to collect GCF from periodontitis
patients (Gangbar et al. 1990; Nwhator et al. 2014; Heikkinen et al.
2016; Räisänen et al. 2019a). The aim of this note is to providemore ac-
curate assessment of the efﬁciency of mouthrinse vs. salivary aMMP-8
analysis in discrimination of periodontal health and disease.
Fig. 1 illustrates the ability of aMMP-8 PoC mouthrinse test com-
pared to aMMP-8 IFMA measured from saliva, and it clearly shows
how saliva is inferior to mouthrinse in aMMP-8 measurements related
to identifying periodontal health and disease. There is a signiﬁcant asso-
ciation between the aMMP-8 PoC mouthrinse test result and aMMP-8
IFMA levels in saliva in this sample of adolescents, as has been shown
recently by Räisänen et al. (2019b). However, if patient's periodontal
health is considered, the distinction of salivary aMMP-8 IFMAmeasure-
ments is far from perfect between a positive and negative test result.
aMMP-8 IFMA concentrations vary between similar maximum and
minimum levels independent of the patient's number of sites (0 or 1,
and 2 or more) with ≥4 mm periodontal pockets. On the contrary, the
aMMP-8 mouthrinse test is very sensitive for at least 2 sites with
Fig. 1. aMMP-8 IFMA (ng/mL) concentrations in saliva according to periodontal pocket (≥4mm) status (0 or 1 [PD#= 0–1], and 2 or more [PD# ≥ 2] periodontal pockets) categorized by
the corresponding aMMP-8 PoC test result measured from oral mouthrinse.
2 I.T. Räisänen et al. / Diagnostic Microbiology and Infectious Disease 95 (2019) 114871periodontal pockets (Nwhator et al. 2014; Heikkinen et al. 2016;
Räisänen et al. 2019a). It is instructive that the sensitivity regarding
2 sites with periodontal pockets of ≥4 mm had been reported in
2014 long before it was mentioned in the latest classiﬁcation
(Tonetti et al. 2018).
As indicated in Fig. 1, aMMP-8 PoC mouthrinse test functions much
better and more precisely, which suggests that mouthrinse aMMP-8
measurements are the optimal way of analyzing patient's risk for active
periodontal tissue destruction and progression of periodontal disease.
Furthermore, the use of mouthrinse aMMP-8 tomeasure active collage-
nases avoids the interference by tissue inhibitors of metalloproteinase
(TIMPs) when saliva is used (Drouin et al. 1988; Gangbar et al. 1990).
In accordance with the original ﬁndings of Drouin et al. (1988) and
Gangbar et al. (1990), as well the recent studies using the aMMP-8
chairside PoC tests (Nwhator et al. 2014; Izadi Borujeni et al. 2015;
Heikkinen et al. 2016; Johnson et al. 2016; Sorsa et al. 2016; Heikkinen
et al. 2017; Lorenz et al. 2017; Alassiri et al. 2018; Leppilahti et al. 2018;
Räisänen et al. 2018; Schmidt et al. 2018; Schmalz et al. 2019; Räisänen
et al. 2019a), repeatedly and strongly indicate that aMMP-8 or active
neutrophil collagenase present in mouthrinse is derived from GCF and
neutrophils. Regarding saliva, there aremultiple other potential sources
for aMMP-8 in addition to neutrophils (Rathnayake et al., 2017). Over-
all, mouthrinse provides calibration and standardization of the GCF
and its aMMP-8 biomarker to be quantitatively analyzed (Nwhator
et al. 2014; Izadi Borujeni et al. 2015; Heikkinen et al. 2016; Johnson
et al. 2016; Sorsa et al. 2016; Heikkinen et al. 2017; Lorenz et al. 2017;
Sorsa et al. 2017; Alassiri et al. 2018; Leppilahti et al. 2018; Räisänen
et al. 2018; Schmidt et al. 2018; Schmalz et al. 2019; Räisänen et al.
2019a). Additional studies have further shown that aMMP-8, but not
total MMP-8, can predict and differentiate between “active” and “inac-
tive” periodontal pockets (Lee et al. 1995; Mancini et al. 1999;
Romanelli et al. 1999; Kiili et al. 2002; Sorsa et al. 2006), and
standard-of-care treatment (i.e., scaling and root planing) reduces
aMMP-8 levels in oral ﬂuid (GCF and mouthrinse) and, at the same
time, ceases the clinical progression of the disease (Mäntylä et al.2003; Leppilahti et al. 2014; Leppilahti et al. 2015; Alassiri et al. 2018).
Elevation of aMMP-8 (N20 ng/mL) by 2 or even 1 active deep site is re-
quired for the chairside PoC test to be positive to indicate increased risk
for periodontitis and/or its development and progression, thus
reﬂecting the high sensitivity of commercially available aMMP-8 PoC
mouthrinse test (Nwhator et al. 2014; Heikkinen et al. 2016; Räisänen
et al. 2019a). This was also originally observed for active collagenase ac-
tivity by Gangbar et al. (1990). Salivary analysis of periodontitis bio-
markers is on the other hand less exact and potentially erroneous
(Fig. 1). Thus, the aMMP-8 oral ﬂuid test is a mouthrinse—not salivary
—test addressing GCF/PISF aMMP-8 in periodontal disease.References
Alassiri S, Parnanen P, Rathnayake N, Johannsen G, Heikkinen AM, Lazzara R, et al. The
ability of quantitative, speciﬁc, and sensitive point-of-care/chair-side oral ﬂuid
immunotests for aMMP-8 to detect periodontal and peri-implant diseases. Dis
Markers 2018;1306396. https://doi.org/10.1155/2018/1306396.
Drouin L, Overall CM, Sodek J. Identiﬁcation of matrix metalloendoproteinase inhibitor
(TIMP) in human parotid and submandibular saliva: partial puriﬁcation and charac-
terization. J Periodontal Res 1988;23:370–7.
Gangbar S, Overall CM,McCulloch CA, Sodek J. Identiﬁcation of polymorphonuclear leuko-
cyte collagenase and gelatinase activities in mouthrinse samples: correlation with
periodontal disease activity in adult and juvenile periodontitis. J Periodontal Res
1990;25:257–67.
Heikkinen AM, Nwhator SO, Rathnayake N, Mäntylä P, Vatanen P, Sorsa T. Pilot study on
oral health status as assessed by an active matrix metalloproteinase-8 chairside
mouthrinse test in adolescents. J Periodontol 2016;87:36–40. https://doi.org/10.
1902/jop.2015.150377.
Heikkinen AM, Raivisto T, Kettunen K, Kovanen L, Haukka J, Pakbaznejad Esmaeili E, et al.
Pilot study on the genetic background of an active matrix metalloproteinase-8 test in
Finnish adolescents. J Periodontol 2017;88:464–72. https://doi.org/10.1902/jop.2016.
160441.
Izadi Borujeni S, Mayer M, Eickholz P. Activated matrix metalloproteinase-8 in saliva as
diagnostic test for periodontal disease? A case–control study. Med Microbiol
Immunol 2015;204:665–72. https://doi.org/10.1007/s00430-015-0413-2.
Johnson N, Ebersole JL, Kryscio RJ, Danaher RJ, Dawson 3rd D, Al-Sabbagh M, et al. Rapid
assessment of salivary MMP-8 and periodontal disease using lateral ﬂow immunoas-
say. Oral Dis 2016;22:681–7. https://doi.org/10.1111/odi.12521.
Kiili M, Cox SW, Chen HY,Wahlgren J, Maisi P, Eley BM, et al. Collagenase-2 (MMP-8) and
collagenase-3 (MMP-13) in adult periodontitis: molecular forms and levels in
3I.T. Räisänen et al. / Diagnostic Microbiology and Infectious Disease 95 (2019) 114871gingival crevicular ﬂuid and immunolocalisation in gingival tissue. J Clin Periodontol
2002;29:224–32. https://doi.org/10.1034/j.1600-051x.2002.290308.x.
LeeW, Aitken S, Sodek J, McCulloch CA. Evidence of a direct relationship between neutro-
phil collagenase activity and periodontal tissue destruction in vivo: role of active en-
zyme in human periodontitis. J Periodontal Res 1995;30:23–33. https://doi.org/10.
1111/j.1600-0765.1995.tb01249.x.
Leppilahti JM, Kallio MA, Tervahartiala T, Sorsa T, Mäntylä P. Gingival crevicular ﬂuid matrix
metalloproteinase-8 levels predict treatment outcome among smokers with chronic
periodontitis. J Periodontol 2014;85:250–60. https://doi.org/10.1902/jop.2013.130156.
Leppilahti JM, Sorsa T, KallioMA, Tervahartiala T, Emingil G, Han B, et al. The utility of gin-
gival crevicular ﬂuid matrix metalloproteinase-8 response patterns in prediction of
site-level clinical treatment outcome. J Periodontol 2015;86:777–87. https://doi.
org/10.1902/jop.2015.140421.
Leppilahti JM, Harjunmaa U, Järnstedt J, Mangani C, Hernández M, Tervahartiala T, et al.
Diagnosis of newly delivered mothers for periodontitis with a novel oral-rinse
aMMP-8 point-of-care test in a rural Malawian population. Diagnostics (Basel)
2018;8, E67. https://doi.org/10.3390/diagnostics8030067.
Lorenz K, Keller T, Noack B, Freitag A, Netuschil L, Hoffmann T. Evaluation of a novel
point-of-care test for active matrixmetalloproteinase-8: agreement between qualita-
tive and quantitative measurements and relation to periodontal inﬂammation. J Peri-
odontal Res 2017;52:277–84. https://doi.org/10.1111/jre.12392.
Mancini S, Romanelli R, Laschinger CA, Overall CM, Sodek J, McCulloch CA. Assessment of a
novel screening test for neutrophil collagenase activity in the diagnosis of periodontal dis-
eases. J Periodontol 1999;70:1292–302. https://doi.org/10.1902/jop.1999.70.11.1292.
Mäntylä P, Stenman M, Kinane DF, Tikanoja S, Luoto H, Salo T, et al. Gingival crevicular ﬂuid
collagenase-2 (MMP-8) test stick for chair-side monitoring of periodontitis. J Periodon-
tal Res 2003;38:436–9. https://doi.org/10.1034/j.1600-0765.2003.00677.x.
Nwhator SO, Ayanbadejo PO, Umeizudike KA, Opeodu OI, Agbelusi GA, Olamijulo JA, et al.
Clinical correlates of a lateral-ﬂow immunoassay oral risk indicator. J Periodontol
2014;85:188–94. https://doi.org/10.1902/jop.2013.130116.
Räisänen IT, Heikkinen AM, Siren E, Tervahartiala T, Gieselmann DR, van der Schoor GJ,
et al. Point-of-care/chairside aMMP-8 analytics of periodontal diseases' activity and
episodic progression. Diagnostics (Basel) 2018;8, E74. https://doi.org/10.3390/
diagnostics8040074.
Räisänen IT, Sorsa T, van der Schoor G-J, Tervahartiala T, van der Schoor P, Gieselmann DR,
et al. Active matrix metalloproteinase-8 point-of-care (PoC) / chairside mouthrinsetest vs bleeding on probing in diagnosing subclinical periodontitis in adolescents. Di-
agnostics (Basel) 2019a;9, E34. https://doi.org/10.3390/diagnostics9010034.
Räisänen IT, Heikkinen AM, Pakbaznejad Esmaeili E, Tervahartiala T, Pajukanta R,
Silbereisen A, Bostanci N, Sorsa T. A point-of-care test of active matrix metallopro-
teinase-8 (aMMP-8) predicts triggering receptor expressed on myeloid cells-1
(TREM-1) levels in saliva. J Periodontol 2019b;1–8. https://doi.org/10.1002/JPER.19-
0132.
Rathnayake N, Gieselmann DR, Heikkinen AM, Tervahartiala T, Sorsa T. Salivary diagnos-
tics-point-of-care diagnostics of MMP-8 in dentistry and medicine. Diagnostics
(Basel) 2017;7, E7. https://doi.org/10.3390/diagnostics7010007.
Romanelli R, Mancini S, Laschinger C, Overall CM, Sodek J, McCulloch CA. Activation
of neutrophil collagenase in periodontitis. Infect Immun 1999;67:2319–26.
[PubMed].
Schmalz G, Hübscher AE, Angermann H, Schmidt J, Schmickler J, Legler TJ, et al. Associa-
tions of chairside salivary aMMP-8 ﬁndings with periodontal parameters, potentially
periodontal pathogenic bacteria and selected blood parameters in systemically
healthy adults. Diagn Microbiol Infect Dis 2019(19):S0732–8893. https://doi.org/10.
1016/j.diagmicrobio.2019.05.006. 30094-X.
Schmidt J, Guder U, Kreuz M, Löfﬂer M, Kiess W, Hirsch C, et al. aMMP-8 in correlation to
caries and periodontal condition in adolescents-results of the epidemiologic LIFE
child study. Clin Oral Investig 2018;22:449–60. https://doi.org/10.1007/s00784-
017-2132-0.
Sorsa T, Tjäderhane L, Konttinen YT, Lauhio A, Salo T, Lee HM, et al. Matrix metallo-
proteinases: contribution to pathogenesis, diagnosis and treatment of periodon-
tal inﬂammation. Ann Med 2006;38:306–21. https://doi.org/10.1080/
07853890600800103.
Sorsa T, Gürsoy UK, Nwhator S, Hernandez M, Tervahartiala T, Leppilahti J, et al. Analysis
of matrix metalloproteinases, especially MMP-8, in gingival crevicular ﬂuid,
mouthrinse and saliva for monitoring periodontal diseases. Periodontology 2000
2016;70:142–63. https://doi.org/10.1111/prd.12101.
Sorsa T, Gieselmann D, Arweiler NB, Hernández M. A quantitative point-of-care test for
periodontal and dental peri-implant diseases. Nat Rev Dis Primers 2017;3:17069.
https://doi.org/10.1038/nrdp.2017.69.
Tonetti MS, Greenwell H, Kornman KS. Staging and grading of periodontitis: framework
and proposal of a new classiﬁcation and case deﬁnition. J Periodontol 2018;89
(Suppl. 1):S159–72. https://doi.org/10.1002/JPER.18-0006.
